The Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) data package contains information on medication errors, quality complaints and drug-related adverse events that were submitted to FDA in 2014.
FAERS data package is designed to support the FDA's post-marketing safety surveillance program for drug and therapeutic biologic products. It is a useful tool for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance with reporting regulations and responding to outside requests for information. The reports in FAERS are evaluated by clinical reviewers, in the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER), to monitor the safety of products after they are approved by FDA. These reports are submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others) and consumers (such as patients, family members, lawyers and others). Healthcare professionals and consumers may also report to the products’ manufacturers who then send these reports to the FDA. The datasets in FAERS data package contain much relevant information such as patient demographics, drug name, dose and route of administration, diagnosis and indication for use, therapy starts and ends date and patient outcome.
License Information
The use of John Snow Labs datasets is free for personal and research purposes. For commercial use please subscribe to the Data Library on AWS. The subscription will allow you to use all John Snow Labs datasets and data packages for commercial purposes.
Metadata
Description
Value
Data Package Complexity
Medium
Available Enrichments
N/A
Keywords
Adverse Reaction, Adverse Events in Healthcare, Adverse Event Reporting Form, FAERS, Serious Adverse Event, Adverse Events Reporting System
Other Titles
FDA Adverse Event Reporting Guidance, Adverse Event Database by FDA 2014, FDA Post-Marketing Surveillance Reports 2014, FDA Drugs Causing Serious Adverse Effects 2014, FDA Reporting System of Adverse Effects 2014
Included Datasets
FDA Adverse Events Reporting System Demographics 2014
FAERS database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products. The Demographics data file contains patient demographic and administrative information, a single record for each event report.
FDA Adverse Events Reporting System Drug 2014
FAERS database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products. The Drug file contains drug/biologic information for as many medications as were reported for the event (1 or more per event).
FDA Adverse Events Reporting System Drug Indication 2014
FAERS database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products. The Indication file contains all "Medical Dictionary for Regulatory Activities" (MedDRA) terms coded for the indications for use (diagnoses) for the reported drugs (0 or more per drug per event).
FDA Adverse Events Reporting System Drug Reaction 2014
FAERS database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products. The Reaction file contains all "Medical Dictionary for Regulatory Activities" (MedDRA) terms coded for the adverse event (1 or more).
FDA Adverse Events Reporting System Drug Therapy Dates 2014
FAERS database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products. The Drug Therapy Dates file contains drug therapy start dates and end dates for the reported drugs (0 or more per drug per event).
FDA Adverse Events Reporting System Patient Outcome 2014
FAERS database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products. The Outcome file contains patient outcomes for the event (0 or more).
FDA Adverse Events Reporting System Report Source 2014
FAERS database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products. The Report Source file contains report sources for event (0 or more).
FDA Adverse Events Reporting System Reporter Type 2014
FAERS database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products. The Reporter Type file contains counts and percentage of the reports submitted to the FDA during the quarter.
Data Engineering Overview
We deliver high-quality data
Each dataset goes through 3 levels of quality review
2 Manual reviews are done by domain experts
Then, an automated set of 60+ validations enforces every datum matches metadata & defined constraints
Data is normalized into one unified type system
All dates, unites, codes, currencies look the same
All null values are normalized to the same value
All dataset and field names are SQL and Hive compliant
Data and Metadata
Data is available in both CSV and Apache Parquet format, optimized for high read performance on distributed Hadoop, Spark & MPP clusters
Metadata is provided in the open Frictionless Data standard, and its every field is normalized & validated
Data Updates
Data updates support replace-on-update: outdated foreign keys are deprecated, not deleted
Our data is curated and enriched by domain experts
Each dataset is manually curated by our team of doctors, pharmacists, public health & medical billing experts:
Field names, descriptions, and normalized values are chosen by people who actually understand their meaning
Healthcare & life science experts add categories, search keywords, descriptions and more to each dataset
Both manual and automated data enrichment supported for clinical codes, providers, drugs, and geo-locations
The data is always kept up to date – even when the source requires manual effort to get updates
Support for data subscribers is provided directly by the domain experts who curated the data sets
Every data source’s license is manually verified to allow for royalty-free commercial use and redistribution.
John Snow Labs, an AI and NLP for healthcare company, provides state-of-the-art software, models, and data to help healthcare and life science organizations build, deploy, and operate AI projects.
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing has one pricing dimension: Product Access (Units). It grants subscribers access to the dataset at no cost. There are no tiers, instance sizes, or usage-based add-ons to compare. You subscribe once to unlock access, and pricing does not scale with the number of records, users, or queries. Because the product is free, no charges apply to your bill for this dimension.
Top-of-mind questions for buyers
What does one unit of Product Access grant me?
One unit unlocks access to the FAERS 2014 dataset for your subscription. There is no metering by records, users, or queries. You subscribe once to gain access, and a single unit covers the full dataset at no cost.
Are subscriptions to this dataset refundable if I cancel?
Active data library subscriptions can be canceled at any time, which stops future renewal charges. However, the vendor does not reimburse subscriptions already paid. Since this listing is free, no charges apply, so cancellation does not affect your bill.
Do I have to share my data with the vendor when using this dataset?
No. You run the software on your own infrastructure. It does not "call home," and no data or results are sent to the vendor. This design suits high-compliance environments handling sensitive information.
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
The Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) data package contains information on medication errors, quality complaints and drug-related adverse events that were submitted to FDA in 2019.
The Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) data package contains information on medication errors, quality complaints and drug-related adverse events that were submitted to FDA in 2018.
The Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) data package contains information on medication errors, quality complaints and drug-related adverse events that were submitted to FDA in 2021.
The Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) data package contains information on medication errors, quality complaints and drug-related adverse events that were submitted to FDA in 2020.